↓ Skip to main content

Isolation and Molecular Characterization of Circulating Tumor Cells

Overview of attention for book
Cover of 'Isolation and Molecular Characterization of Circulating Tumor Cells'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Circulating Tumor Cells as Cancer Biomarkers in the Clinic
  3. Altmetric Badge
    Chapter 2 Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells
  4. Altmetric Badge
    Chapter 3 Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics
  5. Altmetric Badge
    Chapter 4 Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
  6. Altmetric Badge
    Chapter 5 Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis
  7. Altmetric Badge
    Chapter 6 Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration
  8. Altmetric Badge
    Chapter 7 Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype
  9. Altmetric Badge
    Chapter 8 Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures
  10. Altmetric Badge
    Chapter 9 Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer
  11. Altmetric Badge
    Chapter 10 Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells
  12. Altmetric Badge
    Chapter 11 Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells
  13. Altmetric Badge
    Chapter 12 Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer
  14. Altmetric Badge
    Chapter 13 Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells
  15. Altmetric Badge
    Chapter 14 Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells
  16. Altmetric Badge
    Chapter 15 Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells
  17. Altmetric Badge
    Chapter 16 Significance of EGFR Expression in Circulating Tumor Cells
Attention for Chapter 1: Circulating Tumor Cells as Cancer Biomarkers in the Clinic
Altmetric Badge

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Circulating Tumor Cells as Cancer Biomarkers in the Clinic
Chapter number 1
Book title
Isolation and Molecular Characterization of Circulating Tumor Cells
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/978-3-319-55947-6_1
Pubmed ID
Book ISBNs
978-3-31-955946-9, 978-3-31-955947-6
Authors

Ludmilla Thomé Domingos Chinen, Emne Ali Abdallah, Alexcia Camila Braun, Bianca de Cássia Troncarelli de Campos Parra Flores, Marcelo Corassa, Solange Moraes Sanches, Marcello Ferretti Fanelli, Chinen, Ludmilla Thomé Domingos, Abdallah, Emne Ali, Braun, Alexcia Camila, Flores, Bianca de Cássia Troncarelli de Campos Parra, Corassa, Marcelo, Sanches, Solange Moraes, Fanelli, Marcello Ferretti

Abstract

It is believed that the development of metastatic cancer requires the presence of circulating tumor cells (CTCs) , which are found in a patient's circulation as rare abnormal cells comingled with billions of the normal red and white blood cells. The systems developed for detection of CTCs have brought progress to cancer treatment. The molecular characterization of CTCs can aid in the development of new drugs, and their presence during treatment can help clinicians determine the prognosis of the patient. Studies have been carried out in patients early in the disease course, with only primary tumors, and the role of CTCs in prognosis seems to be as important as it is in patients with metastatic disease. The published studies on CTCs have focused on their prognostic significance, their utility in real-time monitoring of therapies, the identification of therapeutic and resistance targets, and understanding the process of metastasis . The analysis of CTCs during the early stages, as a "liquid biopsy," helps to monitor patients at different points in the disease course, including minimal residual disease, providing valuable information about the very early assessment of treatment effectiveness. Finally, CTCs can be used to screen patients with family histories of cancer or with diseases that can lead to the development of cancer. With standard protocols, this easily obtained and practical tool can be used to prevent the growth and spread of cancer. In this chapter, we review some important aspects of CTCs , surveying the disease aspects where these cells have been investigated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 17%
Student > Bachelor 6 12%
Student > Master 5 10%
Student > Doctoral Student 4 8%
Researcher 3 6%
Other 9 17%
Unknown 16 31%
Readers by discipline Count As %
Medicine and Dentistry 7 13%
Engineering 7 13%
Biochemistry, Genetics and Molecular Biology 5 10%
Agricultural and Biological Sciences 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Other 10 19%
Unknown 16 31%